Gene · 4585
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms. | Lancet Gastroenterol Hepatol | 2022 | 36057265 | PubTator, text mining | PubMed |
| A comprehensive prognostic and immunological analysis of ephrin family genes in hepatocellular carcinoma. | Front Mol Biosci | 2022 | 36052169 | PubTator, text mining | PubMed |
| Low-Grade Fibromyxoid Sarcoma Featuring an Unusual EWSR1-CREB3L2 Gene Fusion: Report of a Rare Case Arising in the Parotid Gland. | Avicenna J Med | 2022 | 36051504 | PubTator, text mining | PubMed |
| Mucin O-glycan-microbiota axis orchestrates gut homeostasis in a diarrheal pig model. | Microbiome | 2022 | 36045454 | PubTator, text mining | PubMed |
| Single-cell RNA transcriptomic analysis identifies Creb5 and CD11b-DCs as regulator of asthma exacerbations. | Mucosal Immunol | 2022 | 36038770 | PubTator, text mining | PubMed |
| Diquafosol ophthalmic solution enhances mucin expression via ERK activation in human conjunctival epithelial cells with hyperosmotic stress. | Mol Vis | 2022 | 36034736 | PubTator, text mining | PubMed |
| Unearthing novel fusions as therapeutic targets in solid tumors using targeted RNA sequencing. | Front Oncol | 2022 | 36033527 | PubTator, text mining | PubMed |
| A mechanism of gene evolution generating mucin function. | Sci Adv | 2022 | 36026444 | PubTator, text mining | PubMed |
| Microbiomes, Epigenomics, Immune Response, and Splicing Signatures Interplay: Potential Use of Combination of Regulatory Pathways as Targets for Malignant Mesothelioma. | Int J Mol Sci | 2022 | 36012262 | PubTator, text mining | PubMed |
| Overcoming Resistance to HER2-Directed Therapies in Breast Cancer. | Cancers (Basel) | 2022 | 36010990 | PubTator, text mining | PubMed |
| Diagnosis Biomarkers of Cholangiocarcinoma in Human Bile: An Evidence-Based Study. | Cancers (Basel) | 2022 | 36010914 | PubTator, text mining | PubMed |
| Circulating Cells with Macrophage-like Characteristics in Cancer: The Importance of Circulating Neoplastic-Immune Hybrid Cells in Cancer. | Cancers (Basel) | 2022 | 36010865 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Genomic Alterations in Hepatoid Adenocarcinoma of the Stomach and Identification of Clinically Actionable Alterations. | Cancers (Basel) | 2022 | 36010842 | PubTator, text mining | PubMed |
| Integrated Analysis of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma. | Diagnostics (Basel) | 2022 | 36010268 | PubTator, text mining | PubMed |
| Comprehensive analyses unveil novel genomic and immunological characteristics of micropapillary pattern in lung adenocarcinoma. | Front Oncol | 2022 | 35992814 | PubTator, text mining | PubMed |
| Primary malignant epithelioid hemangioendothelioma of the pleura: A review and report of a novel case. | Clin Case Rep | 2022 | 35979384 | PubTator, text mining | PubMed |
| Multiple roles for cholinergic signaling in pancreatic diseases. | World J Gastroenterol | 2022 | 35978870 | PubTator, text mining | PubMed |
| The LINC00623/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA. | J Hematol Oncol | 2022 | 35978332 | PubTator, text mining | PubMed |
| m6A-related metabolism molecular classification with distinct prognosis and immunotherapy response in soft tissue sarcoma. | Front Immunol | 2022 | 35967408 | PubTator, text mining | PubMed |
| A brief overview about the adipokine: Isthmin-1. | Front Cardiovasc Med | 2022 | 35958402 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4585/papers?page=46